Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ESALY
Recent news which mentions ESALY
< Previous
1
2
3
4
Next >
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
March 22, 2024
Tickers
BIIB
ESALF
ESALY
NEWS
Tags
General
News
Briefs
From
Benzinga
Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision
March 08, 2024
Tickers
BIIB
ESALY
LLY
NEWS
Tags
Stories That Matter
General
why it's moving
From
Benzinga
Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says
February 14, 2024
Tickers
BIIB
ESALY
NEWS
NVS
Tags
Health Care
BIIB
Large Cap
From
Benzinga
Why Is Biogen Stock Trading Lower On Tuesday?
February 13, 2024
Tickers
BIIB
ESALY
NEWS
Tags
Benzinga
Market News
Health Care
From
Benzinga
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
January 12, 2024
Tickers
BIIB
DGX
ESALY
LH
Tags
LLY
LH
Benzinga
From
Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
December 08, 2023
Tickers
ESALF
ESALY
MRK
Tags
Market News
MRK
Benzinga
From
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Tickers
ACIU
BIIB
ESAIY
ESALY
Tags
Large Cap
Alzheimer's disease
AI Generated
From
Benzinga
Biogen Revises Annual Forecast As Reata M&A And Alzheimer's Drug Expenses Hit Bottomline, Stock Slides
November 08, 2023
Tickers
BIIB
ESALY
Tags
Biotech
BIIB
Health Care
From
Benzinga
Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage
October 13, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
ESALF
News
Briefs
From
Benzinga
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
October 11, 2023
Tickers
BIIB
DGX
ESALY
LH
Tags
Health Care Services
AI Generated
Health Care
From
Benzinga
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
October 10, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Biotech
BIIB
AI Generated
From
Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
September 25, 2023
Tickers
AA
AAPL
AMZN
BIIB
Tags
RNAZ
F
WMT
From
Benzinga
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
September 25, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Briefs
News
Biotech
From
Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
September 22, 2023
Tickers
ESALF
ESALY
MRK
Tags
General
ESALY
News
From
Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
August 25, 2023
Tickers
ESALF
ESALY
MRK
Tags
Biotech
Large Cap
Health Care
From
Benzinga
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
August 01, 2023
Tickers
BIIB
ESALY
RETA
Tags
BIIB
Recent Press Releases
RETA
From
Motley Fool
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
July 07, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed
June 14, 2023
Tickers
BIIB
ESALY
Tags
Market News
Benzinga
ESALY
From
Benzinga
FTC Sues To Block Microsoft-Activision Blizzard Deal, Netflix's First Sports Streaming Debut, EU Mulls Antitrust Case Against Google's Ad-Tech Business: Today's Top Stories
June 13, 2023
Tickers
AAPL
ATVI
BEP
BIIB
Tags
ATVI
NEX
General
From
Benzinga
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
June 13, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Top Stories
Markets
ESALF
From
Benzinga
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
June 12, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Large Cap
Biotech
Health Care
From
Benzinga
Nasdaq, S&P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
June 12, 2023
Tickers
BIIB
ESALY
ILMN
KDNY
Tags
Market News
ILMN
Adam Turnquist
From
Benzinga
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
June 08, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Market News
Alzheimer’s
Benzinga
From
Benzinga
Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories
June 08, 2023
Tickers
AMZN
BLK
DIS
EADSY
Tags
AMZN
General
GOOG
From
Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
June 08, 2023
Tickers
BIIB
ESALF
ESALY
Tags
ESALY
Briefs
News
From
Benzinga
Medtronic, Merck, Williams Companies And More: CNBC's 'Final Trades'
June 01, 2023
Tickers
ESALY
IEF
MDT
MRK
Tags
WMB
Benzinga
Trading Ideas
From
Benzinga
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
May 26, 2023
Tickers
ESALY
MRK
PFE
Tags
Health Care
General
ESALY
From
Benzinga
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
May 04, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Large Cap
Biotech
BIIB
From
Benzinga
Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
April 21, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
ESALF
News
Briefs
From
Benzinga
Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer
April 10, 2023
Tickers
ESALF
ESALY
MRK
Tags
ESALF
ESALY
News
From
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.